Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Training Experience Required

  • Proficient in written and spoken English
  • MBBS and MRCP or acceptable equivalent qualifications
  • GMC Full registration with a license to practice
  • Relevant clinical and research experience for the proposed fellowship; a minimum of 2 years of medical or clinical oncological training are essential for clinical fellowships

General description of the hospital

The Birmingham cancer centre is based in the Queen Elizabeth Hospital Birmingham (QEH) on the main hospital site in Edgbaston. The QEH is part of the University Hospitals of Birmingham (UHB) comprising in addition Birmingham Heartlands Hospital, Solihull Hospital and Community Services, Good Hope Hospital in Sutton Coldfield and the Birmingham Chest Clinic. The trust is one of the largest teaching hospital in England treating 2.2 million people every year.

Expertise of the hospital

  • Regional and national genomic profiling centre with molecular pathology expertise onsite and monthly genomic tumour board meetings
  • Experimental Cancer Medicines unit and Birmingham CRUK centre/CRUK clinical trials unit focusing on early phase trials and translational research with a portfolio of national academic investigator lead and commercial trials.
  • Part of the Midlands and Wales Advanced Therapy Treatment Centre delivering advanced cell therapies in haematological and solid tumours.


The cancer centre in QEH provides radiotherapy and chemotherapy services through dedicated units for adults and young persons (in the Young Persons Unit supported by the Teenage Cancer Trust). The Birmingham centre for clinical trials is formed of the Birmingham Experimental Cancer Medicine Centre, the Birmingham Cancer Research UK Cancer Centre and the West Midland Cancer Research UK Clinical Trials Unit. It is one of the largest cancer trials units in the UK. There are a number of national trial and translational research programmes initiated and run out of Birmingham including The National Lung Matrix trial and the Brain Matrix programme. QEH is one of the three ATTC (advanced therapies treatment centres) delivering cell therapies for the Midlands and Wales.

The University of Birmingham medical school and main campus are adjacent to the QEH site and there are close working links between the two. University research facilities on the QEHB site provide laboratories for high quality basic research in diverse fields including Immunology and Cell Signalling, Molecular Medicine, Oncology and Cancer Studies. There are opportunities to study for higher degrees including the University's Msc/diploma in clinical trials.

Host Institute University Hospital Birmingham

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings